Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Environ Mol Mutagen ; 61(2): 276-290, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31633839

RESUMO

The National Toxicology Program tested two common radiofrequency radiation (RFR) modulations emitted by cellular telephones in a 2-year rodent cancer bioassay that included interim assessments of additional animals for genotoxicity endpoints. Male and female Hsd:Sprague Dawley SD rats and B6C3F1/N mice were exposed from Gestation day 5 or Postnatal day 35, respectively, to code division multiple access (CDMA) or global system for mobile modulations over 18 hr/day, at 10-min intervals, in reverberation chambers at specific absorption rates of 1.5, 3, or 6 W/kg (rats, 900 MHz) or 2.5, 5, or 10 W/kg (mice, 1,900 MHz). After 19 (rats) or 14 (mice) weeks of exposure, animals were examined for evidence of RFR-associated genotoxicity using two different measures. Using the alkaline (pH > 13) comet assay, DNA damage was assessed in cells from three brain regions, liver cells, and peripheral blood leukocytes; using the micronucleus assay, chromosomal damage was assessed in immature and mature peripheral blood erythrocytes. Results of the comet assay showed significant increases in DNA damage in the frontal cortex of male mice (both modulations), leukocytes of female mice (CDMA only), and hippocampus of male rats (CDMA only). Increases in DNA damage judged to be equivocal were observed in several other tissues of rats and mice. No significant increases in micronucleated red blood cells were observed in rats or mice. In conclusion, these results suggest that exposure to RFR is associated with an increase in DNA damage. Environ. Mol. Mutagen. 61:276-290, 2020. © 2019 Wiley Periodicals, Inc.


Assuntos
Telefone Celular , Dano ao DNA , Ondas de Rádio/efeitos adversos , Animais , Ensaio Cometa , Feminino , Masculino , Camundongos , Testes para Micronúcleos , Ratos , Ratos Sprague-Dawley
2.
Bioelectromagnetics ; 39(3): 190-199, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29537695

RESUMO

Radiofrequency radiation (RFR) causes heating, which can lead to detrimental biological effects. To characterize the effects of RFR exposure on body temperature in relation to animal size and pregnancy, a series of short-term toxicity studies was conducted in a unique RFR exposure system. Young and old B6C3F1 mice and young, old, and pregnant Harlan Sprague-Dawley rats were exposed to Global System for Mobile Communication (GSM) or Code Division Multiple Access (CDMA) RFR (rats = 900 MHz, mice = 1,900 MHz) at specific absorption rates (SARs) up to 12 W/kg for approximately 9 h a day for 5 days. In general, fewer and less severe increases in body temperature were observed in young than in older rats. SAR-dependent increases in subcutaneous body temperatures were observed at exposures ≥6 W/kg in both modulations. Exposures of ≥10 W/kg GSM or CDMA RFR induced excessive increases in body temperature, leading to mortality. There was also a significant increase in the number of resorptions in pregnant rats at 12 W/kg GSM RFR. In mice, only sporadic increases in body temperature were observed regardless of sex or age when exposed to GSM or CDMA RFR up to 12 W/kg. These results identified SARs at which measurable RFR-mediated thermal effects occur, and were used in the selection of exposures for subsequent toxicology and carcinogenicity studies. Bioelectromagnetics. 39:190-199, 2018. © 2018 The Authors. Bioelectromagnetics Published by Wiley Periodicals, Inc.


Assuntos
Temperatura Corporal/efeitos da radiação , Telefone Celular , Exposição à Radiação/efeitos adversos , Ondas de Rádio/efeitos adversos , Envelhecimento/fisiologia , Animais , Feminino , Camundongos , Projetos Piloto , Gravidez , Ratos , Ratos Sprague-Dawley
3.
Cutan Ocul Toxicol ; 32(3): 234-40, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23231012

RESUMO

Pyrogallol (CAS No. 87-66-1), a benzenetriol used historically as a hair dye and currently in a number of industrial applications, was nominated to the National Toxicology Program (NTP) for testing based on the lack of toxicity and carcinogenicity data. Three-month and two-year toxicity studies to determine the toxicity and carcinogenicity of pyrogallol when applied to naïve skin (i.e. dermal administration) were conducted in both sexes of F344/N rats and B6C3F1/N mice. In the three-month studies, adult rodents were administered pyrogallol in 95% ethanol five days per week for 3 months at doses of up to 150 mg/kg body weight (rats) or 600 mg/kg (mice). Based on the subchronic studies, the doses for the two-year studies in rats and mice were 5, 20 and 75 mg/kg of pyrogallol. All mice and most rats survived until the end of the three-month study and body weights were comparable to controls. During the two-year study, survival of dosed rats and male mice was comparable to controls; however survival of 75 mg/kg female mice significantly decreased compared to controls. The incidences of microscopic non-neoplastic lesions at the site of application were significantly higher in all dosed groups of rats and mice and in both the 3-months and two-year studies. In the two-year study, hyperplasia, hyperkeratosis and inflammation tended to be more severe in mice than in rats, and in the mice they tended to be more severe in females than in males. The incidence of squamous cell carcinoma at the site of application (SOA) in 75 mg/kg female mice and SOA squamous cell papillomas in 75 mg/kg male mice were greater than controls. Pyrogallol was carcinogenic in female mice and may have caused tumors in male mice.


Assuntos
Carcinógenos/toxicidade , Carcinoma de Células Escamosas/induzido quimicamente , Papiloma/induzido quimicamente , Pirogalol/toxicidade , Neoplasias Cutâneas/induzido quimicamente , Pele/efeitos dos fármacos , Administração Cutânea , Animais , Carcinoma de Células Escamosas/patologia , Feminino , Fibrose/induzido quimicamente , Fibrose/patologia , Tinturas para Cabelo , Hiperplasia/induzido quimicamente , Hiperplasia/patologia , Ceratose/induzido quimicamente , Ceratose/patologia , Masculino , Camundongos , Papiloma/patologia , Ratos , Ratos Endogâmicos F344 , Pele/patologia , Neoplasias Cutâneas/patologia , Testes de Toxicidade Crônica , Testes de Toxicidade Subcrônica
4.
Toxicol Pathol ; 40(4): 561-76, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22328411

RESUMO

To investigate the toxicity and carcinogenic potential of indole-3-carbinol (I3C), the National Toxicology Program has conducted 13-week subchronic studies in Fisher 344 rats and B6C3F1 mice, and chronic 2-year bioassays in Sprague-Dawley rats and B6C3F1 mice. While the chronic study results are not yet available, subchronic study results and short-term special evaluations of interim sacrifices in the 2-year rat bioassay are presented. F344 rats were orally gavaged ≤300 mg I3C/kg body weight 5 days a week for 13 weeks. Rats treated with ≥150 mg/kg demonstrated a dose-related dilation of lymphatics (lymphangiectasis) of the duodenum, jejunum, and mesenteric lymph nodes. Material within dilated lacteals stained positively for Oil Red O and Sudan Black, consistent with lipid. Electron microscopic evaluation confirmed extracellular lipid accumulation within the villar lamina propria, lacteals, and within villar macrophages. Analyses of hepatic and pulmonary CYP1A enzymes demonstrated dose-dependent I3C induction of CYP1A1 and 1A2. B6C3F1 mice orally gavaged ≤250 mg I3C/kg body weight did not demonstrate histopathological changes; however, hepatic CYP induction was similar to that in rats. The histopathologic changes of intestinal lymphangiectasis and lipidosis in this study share similarities with intestinal lymphangiectasia as observed in humans and dogs. However, the resultant clinical spectrum of protein-losing enteropathy was not present.


Assuntos
Indóis/toxicidade , Lipidoses/induzido quimicamente , Linfangiectasia Intestinal/induzido quimicamente , Administração Oral , Animais , Peso Corporal/efeitos dos fármacos , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP1A2/metabolismo , Feminino , Histocitoquímica , Indóis/administração & dosagem , Intestino Delgado/efeitos dos fármacos , Intestino Delgado/metabolismo , Intestino Delgado/patologia , Lipidoses/metabolismo , Lipidoses/patologia , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fígado/metabolismo , Pulmão/efeitos dos fármacos , Pulmão/enzimologia , Pulmão/metabolismo , Linfonodos/efeitos dos fármacos , Linfonodos/metabolismo , Linfonodos/patologia , Linfangiectasia Intestinal/metabolismo , Linfangiectasia Intestinal/patologia , Masculino , Camundongos , Ratos , Ratos Endogâmicos F344 , Ratos Sprague-Dawley , Testes de Toxicidade Crônica , Testes de Toxicidade Subcrônica
5.
Toxicol Pathol ; 38(7): 1037-50, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20924081

RESUMO

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and structurally-similar dioxin-like compounds affect thyroid function and morphology and thyroid hormone metabolism in animals and humans. The National Toxicology Program conducted eight 2-year gavage studies in female Harlan Sprague-Dawley rats to determine the relative potency of chronic toxicity and carcinogenicity of TCDD, 3,3',4,4',5-pentachlorobiphenyl (PCB126), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF), 2,3',4,4',5-pentachlorobiphenyl (PCB118), 2,2',4,4',5,5'-hexachloro-biphenyl (PCB153), a tertiary mixture of TCDD/PCB126/PeCDF, and two binary mixtures (PCB126/PCB153 and PCB126/PCB118). Administration of these compounds was associated with increased incidences of thyroid follicular cell hypertrophy, variably observed in the 14-, 31-, and 53-week interim and 2-year sacrifice groups. In all studies, the incidences of follicular cell adenoma and carcinoma were not increased. Decreased levels of serum thyroxine were primarily noted in the 14-or-later -week interim groups of all chemicals. Serum triiodothyronine (T3) levels were increased in the TCDD, PCB126, PeCDF, TCDD/PCB126/PeCDF, and PCB126/PCB153 studies, while decreased levels were noted in the PCB153 and PCB126/PCB118 studies. TCDD, PCB126, PCB126/PCB153, and PCB126/PCB118 increased levels of serum thyroid-stimulating hormone almost in a dose-dependent manner in the 14-week groups. These data suggest that although dioxin-like compounds alter thyroid hormones and increase follicular cell hyperplasia, there is not an increase in thyroid adenoma or carcinoma in female Sprague-Dawley rats.


Assuntos
Poluentes Ambientais/toxicidade , Dibenzodioxinas Policloradas/toxicidade , Doenças da Glândula Tireoide/induzido quimicamente , Glândula Tireoide/efeitos dos fármacos , Animais , Testes de Carcinogenicidade , Crescimento Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Feminino , Hipertrofia/induzido quimicamente , Hipertrofia/patologia , Dibenzodioxinas Policloradas/análogos & derivados , Ratos , Ratos Sprague-Dawley , Doenças da Glândula Tireoide/sangue , Doenças da Glândula Tireoide/patologia , Glândula Tireoide/patologia , Tireotropina/sangue , Tiroxina/sangue , Testes de Toxicidade Crônica , Tri-Iodotironina/sangue
6.
Toxicol Pathol ; 35(7): 880-9, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18098034

RESUMO

Dioxin and dioxin-related compounds have been associated with high incidences of pulmonary dysfunctions and/or cancers in humans. To evaluate the relative potencies of effects of these compounds, the National Toxicology Program completed a series of two-year bioassays which were conducted using female Harlan Sprague-Dawley rats. The rats were treated orally for up to 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 3,3',4,4',5-pentachlorobiphenyl (PCB126), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF), and a ternary mixture of TCDD, PCB126 and PeCDF. In addition to treatment-related effects reported in other organs, a variety of pulmonary lesions were observed that were related to exposure. Pulmonary CYP1A1-associated 7-ethoxyresorufin-O-deethylase (EROD) activity was increased in all dosed groups. The most common non-neoplastic lesions, which occurred in all studies, were bronchiolar metaplasia and squamous metaplasia of the alveolar epithelium. Cystic keratinizing epithelioma was the most commonly observed neoplasm which occurred in all studies. A low incidence of squamous cell carcinoma was associated only with PCB126 treatment. Potential mechanisms leading to altered differentiation and/or proliferation of bronchiolar and alveolar epithelia may be through CYP1A1 induction or disruption of retinoid metabolism.


Assuntos
Benzofuranos/toxicidade , Pulmão/efeitos dos fármacos , Bifenilos Policlorados/toxicidade , Dibenzodioxinas Policloradas/toxicidade , Administração Oral , Animais , Citocromo P-450 CYP1A1/fisiologia , Feminino , Pulmão/patologia , Metaplasia , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
7.
Mol Nutr Food Res ; 50(10): 934-44, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16977594

RESUMO

The cancer bioassay for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) conducted by the Dow Chemical company in the mid 70s has been used extensively for conducting quantitative cancer risk assessments for human exposure to TCDD. More recently the National Toxicology Program (NTP) conducted a cancer bioassay of similar design as part of its evaluation of the dioxin toxic equivalency factor methodology. This report compares the design and the results of these two cancer bioassays. This comparison confirms, in most cases, previously published and widely used carcinogenic response characteristics with respect to dose, time course, organ selectivity, tumor type and maximum intensity of TCDD-induced carcinogenicity and toxicity in the Sprague-Dawley rat. Specifically, increases in the incidences of neoplasms were seen in both studies in the liver, lung and oral mucosa. The most notable difference was the significant increase in the incidence of cholangiocarcinoma of the liver seen in the NTP study but not in the Dow study. The experimental designs for the two studies are similar but some protocol parameters differed, such as vehicle, dosing schedule, diet and rat sub-strain utilized. Differences in the shapes of the dose response curves for several neoplasms were noted between the studies, with the NTP study showing non-linearity for all neoplasms. This may result from differences in the experimental protocols as well as divergence in the biological behavior of the different stocks of Sprague-Dawley rat strains used.


Assuntos
Testes de Carcinogenicidade , Neoplasias/induzido quimicamente , Dibenzodioxinas Policloradas/toxicidade , Testes de Toxicidade , Animais , Ductos Biliares/patologia , Colangiocarcinoma/induzido quimicamente , Relação Dose-Resposta a Droga , Feminino , Hiperplasia , Cinética , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Bucais/induzido quimicamente , Dibenzodioxinas Policloradas/administração & dosagem , Ratos , Ratos Sprague-Dawley
8.
Toxicol Sci ; 86(2): 281-90, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15901914

RESUMO

The plasticizer di-n-butyl phthalate (DBP) is a reproductive toxicant in rodents. Exposure to DBP in utero at high doses alters early reproductive development in male rats. Di-n-butyl phthalate also affects hepatic and extrahepatic enzymes. The objectives of this study were to determine the responsiveness of steroid-metabolizing enzymes in fetal liver to DBP and to investigate the potential of DBP to activate nuclear receptors that regulate the expression of liver enzymes. Pregnant Sprague-Dawley rats were orally dosed with DBP at levels of 10, 50, or 500 mg/kg/day from gestation days 12 to 19; maternal and fetal liver samples were collected on day 19 for analyses. Increased protein and mRNA levels of CYP 2B1, CYP 3A1, and CYP 4A1 were found in both maternal and fetal liver in the 500-mg dose group. Di-n-butyl phthalate at high doses also caused an increase in the mRNA of hepatic estrogen sulfotransferase and UDP-glucuronosyltransferase 2B1 in the dams but not in the fetuses. Xenobiotic induction of CYP3A1 and 2B1 is known to be mediated by the nuclear hormone receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR). In vitro transcriptional activation assays showed that DBP activates both PXR and CAR. The main DBP metabolite, mono-butyl-phthalate (MBP) did not interact strongly with either CAR or PXR. These data indicate that hepatic steroid- and xenobiotic-metabolizing enzymes are susceptible to DBP induction at the fetal stage; such effects on enzyme expression are likely mediated by xenobiotic-responsive transcriptional factors, including CAR and PXR. Our study shows that DBP is broadly reactive with multiple pathways involved in maintaining steroid and lipid homeostasis.


Assuntos
Dibutilftalato/toxicidade , Feto/efeitos dos fármacos , Fígado/efeitos dos fármacos , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores de Esteroides/metabolismo , Fatores de Transcrição/metabolismo , Animais , Linhagem Celular Tumoral , Receptor Constitutivo de Androstano , Sistema Enzimático do Citocromo P-450/metabolismo , Feminino , Feto/enzimologia , Feto/metabolismo , Humanos , Fígado/embriologia , Fígado/enzimologia , Nível de Efeito Adverso não Observado , PPAR alfa/metabolismo , Gravidez , Receptor de Pregnano X , Ratos , Ratos Sprague-Dawley
9.
Toxicol Pathol ; 33(3): 371-7, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15805076

RESUMO

The National Toxicology Program recently completed a series of studies to evaluate the relative potency for toxicity and carcinogenicity of several polyhalogenated aromatic hydrocarbons including dioxin-like compounds (DLCs) and polychlorinated biphenyls. Female Sprague-Dawley rats were administered by gavage for up to 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD); 3,3',4,4',5-pentachlorobiphenyl (PCB126); 2,3,4,7,8-pentachlorodibenzofuran (PeCDF); 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153); a tertiary mixture of TCDD, PCB126, and PeCDF; a binary mixture of PCB126 and 153; or a binary mixture of PCB126 and 2,3',4,4',5-pentachlorobiphenyl (PCB118); control animals received corn oil-acetone vehicle (99:1) alone. Nasal epithelial changes were observed only in animals exposed for 2 years to the higher doses of the binary mixtures of PCB126 + PCB153 (1000 ng/kg and 1000 microg/kg) and PCB126 + PCB118 (216 and 360 ng TCDD equivalents/kg). In both studies, the changes were of the same nonneoplastic nature, localized to nasal sections II and III located, respectively, at the level of the incisive papilla anterior to the first palatial ridge (section II) and through the middle of the second molar teeth (section III). The changes consisted of hyperplasia of the respiratory epithelium (level II) and metaplasia of olfactory epithelium to respiratory epithelium with further hyperplasia of the metaplastic respiratory epithelium (levels II and III). Variable amounts of acute inflammatory exudate appeared within the lumen of the nasal cavity, overlying the affected epithelium. Occasionally, the inflammation eroded through the skull and into the adjacent olfactory bulbs.


Assuntos
Hiperplasia/patologia , Metaplasia/patologia , Mucosa Olfatória/patologia , Bifenilos Policlorados/toxicidade , Testes de Toxicidade Crônica , Administração Oral , Animais , Relação Dose-Resposta a Droga , Feminino , Hiperplasia/induzido quimicamente , Metaplasia/induzido quimicamente , Estrutura Molecular , Mucosa Olfatória/efeitos dos fármacos , Bifenilos Policlorados/administração & dosagem , Bifenilos Policlorados/química , Ratos , Ratos Sprague-Dawley
10.
Environ Health Perspect ; 113(1): 43-8, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15626646

RESUMO

Use of the dioxin toxic equivalency factor (TEF) approach in human risk assessments assumes that the combined effects of dioxin-like compounds in a mixture can be predicted based on a potency-adjusted dose-additive combination of constituents of the mixture. In this study, we evaluated the TEF approach in experimental 2-year rodent cancer bioassays with female Harlan Sprague-Dawley rats receiving 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 3,3 ,4,4 ,5-pentachlorobiphenyl (PCB-126), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF), or a mixture of the three compounds. Statistically based dose-response modeling indicated that the shape of the dose-response curves for hepatic, lung, and oral mucosal neoplasms was the same in studies of the three individual chemicals and the mixture. In addition, the dose response for the mixture could be predicted from a combination of the potency-adjusted doses of the individual compounds. Finally, we showed that use of the current World Health Organization dioxin TEF values adequately predicted the increased incidence of liver tumors (hepatocellular adenoma and cholangiocarcinoma) induced by exposure to the mixture. These data support the use of the TEF approach for dioxin cancer risk assessments.


Assuntos
Carcinógenos/efeitos adversos , Dioxinas/intoxicação , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Bucais/induzido quimicamente , Animais , Bioensaio , Carcinógenos/administração & dosagem , Dioxinas/administração & dosagem , Relação Dose-Resposta a Droga , Poluentes Ambientais/administração & dosagem , Poluentes Ambientais/intoxicação , Feminino , Humanos , Neoplasias Hepáticas/veterinária , Neoplasias Pulmonares/veterinária , Neoplasias Bucais/veterinária , Dibenzodioxinas Policloradas/administração & dosagem , Dibenzodioxinas Policloradas/intoxicação , Ratos , Ratos Sprague-Dawley , Valores de Referência , Medição de Risco
11.
Toxicol Sci ; 83(1): 64-77, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15509667

RESUMO

We evaluated gingival toxicities induced by chronic exposure of female Harlan Sprague-Dawley rats to dioxin and dioxin-like compounds (DLCs) and compared them to similarly induced oral lesions reported in the literature. This investigation represents part of an ongoing initiative of the National Toxicology Program to determine the relative potency of chronic toxicity and carcinogenicity of polychlorinated dioxins, furans, and biphenyls. For two years, animals were administered by gavage 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD); 3,3',4,4',5-pentachlorobiphenyl (PCB126); 2,3,4,7,8-pentachlorodibenzofuran (PeCDF); 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153); a tertiary mixture of TCDD, PCB126, and PeCDF; a binary mixture of PCB126 and 153; or a binary mixture of PCB126 and 2,3',4,4',5-pentachlorobiphenyl (PCB118); control animals received corn oil-acetone vehicle (99:1) alone. A full complement of tissues, including the palate with teeth, was examined microscopically. In the groups treated with TCDD and the mixtures of TCDD, PCB126, and PeCDF; PCB126 and 153; and PCB126 and 118, the incidences of gingival squamous hyperplasia increased significantly. Moreover, in the groups treated with TCDD, PCB126, and the mixture of PCB126 and 153, squamous cell carcinoma (SCC) in the oral cavity increased significantly. This investigation constitutes the first report documenting that chronic administration of dioxin-like PCBs can induce gingival SCC in rats. These results indicate that dioxin and DLCs target the gingiva of the oral cavity, in particular the junctional epithelium of molars.


Assuntos
Benzofuranos/toxicidade , Carcinoma de Células Escamosas/induzido quimicamente , Gengiva/patologia , Neoplasias Gengivais/induzido quimicamente , Bifenilos Policlorados/toxicidade , Dibenzodioxinas Policloradas/toxicidade , Administração Oral , Animais , Testes de Carcinogenicidade , Carcinoma de Células Escamosas/patologia , Dioxinas/toxicidade , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Feminino , Gengiva/efeitos dos fármacos , Neoplasias Gengivais/patologia , Hiperplasia , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
12.
Toxicol Sci ; 82(1): 34-45, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15282402

RESUMO

Tg.AC mice develop epidermal papillomas in response to treatment with dermally applied nongenotoxic and complete carcinogens. The persistent environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a multi-site rodent carcinogen and tumor promoter that induces the formation of papillomas in Tg.AC mice. To examine the dose-response relationship and compare dermal and oral routes of exposure for TCDD-induced skin papillomas, female Tg.AC mice were exposed dermally to average daily doses of 0, 2.1, 7.3, 15, 33, 52, 71, 152, and 326 ng TCDD/kg/day or 0, 75, 321, and 893 ng TCDD/kg body weight by gavage for 26 weeks. The incidence of cutaneous papillomas was increased in a dose-dependent manner, and tumors developed earlier with higher exposure to TCDD regardless of route of administration. Increased incidences of cutaneous squamous cell carcinomas were observed in mice exposed to dermal (> or =52 ng/kg) and oral (893 ng/kg) TCDD. Higher gavage doses than dermal exposure doses were required to induce papillomas and squamous cell carcinomas. Despite a linear correlation between administered dose and terminal skin concentrations, the incidence of tumor formation was lower in the gavage study than in the dermal study with respect to mean terminal skin TCDD concentrations. These studies demonstrate that, although Tg.AC mice are less responsive to TCDD by gavage than by dermal exposure, the induction of skin neoplasms is a response to systemic exposure and not solely a local response at the site of dermal application. Differences in response between the routes of exposure may reflect pharmacokinetic differences in the delivery of TCDD to the skin over the duration of the study.


Assuntos
Testes de Carcinogenicidade/métodos , Carcinógenos/toxicidade , Carcinoma de Células Escamosas/induzido quimicamente , Poluentes Ambientais/toxicidade , Papiloma/induzido quimicamente , Dibenzodioxinas Policloradas/toxicidade , Neoplasias Cutâneas/induzido quimicamente , Administração Cutânea , Administração Oral , Animais , Carcinógenos/administração & dosagem , Carcinógenos/farmacocinética , Carcinoma de Células Escamosas/patologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Poluentes Ambientais/administração & dosagem , Poluentes Ambientais/farmacocinética , Feminino , Heterozigoto , Camundongos , Camundongos Transgênicos , Papiloma/patologia , Dibenzodioxinas Policloradas/administração & dosagem , Dibenzodioxinas Policloradas/farmacocinética , Pele/efeitos dos fármacos , Pele/metabolismo , Pele/patologia , Neoplasias Cutâneas/patologia , Distribuição Tecidual
13.
Environ Health Perspect ; 112(8): 903-9, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15175180

RESUMO

We evaluated the effect of chronic exposure to dioxin and dioxin-like compounds on the pancreas in female Harlan Sprague-Dawley rats. This investigation represents part of an ongoing National Toxicology Program initiative to determine the relative potency of chronic toxicity and carcinogenicity of polychlorinated dioxins, furans, and biphenyls. Animals were treated by gavage for up to 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 3,3,4,4,5-pentachlorobiphenyl (PCB-126), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF), or a toxic-equivalency-factor (TEF) mixture of these agents; control animals received corn oil-acetone vehicle alone. A complete necropsy was performed on all animals, and a full complement of tissues was collected and examined microscopically. Administration of each of the four compounds was associated with increased incidences of several nonneoplastic changes in the exocrine pancreas, including cytoplasmic vacuolation, chronic active inflammation, atrophy, and arteritis. Low incidences, but higher than those in the historical database, of pancreatic acinar adenoma and carcinoma were seen in the TCDD, PeCDF, and TEF-mixture groups. These results indicate that the pancreatic acini are target tissues for dioxin and certain dioxin-like compounds. Key words: carcinogenesis, dioxin, furans, inflammation, pancreas, polychlorinated biphenyls.


Assuntos
Dioxinas/toxicidade , Poluentes Ambientais/toxicidade , Furanos/toxicidade , Pâncreas/efeitos dos fármacos , Pâncreas/patologia , Bifenilos Policlorados/toxicidade , Dibenzodioxinas Policloradas/toxicidade , Administração Oral , Animais , Dioxinas/administração & dosagem , Poluentes Ambientais/administração & dosagem , Feminino , Furanos/administração & dosagem , Inflamação , Bifenilos Policlorados/administração & dosagem , Dibenzodioxinas Policloradas/administração & dosagem , Ratos , Ratos Sprague-Dawley
14.
Mol Pharmacol ; 64(2): 474-81, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12869653

RESUMO

1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE), a persistent environmental contaminant, is a metabolite of the pesticide 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT). DDE is similar to phenobarbital (PB) in that both compounds are inducers of rat hepatic cytochrome P450 2B and 3A (CYP 2B and 3A). The induction of CYP 2B and 3A by PB is known to be regulated through the nuclear receptors constitutive androstane receptor (CAR) and pregnane X receptor (PXR), respectively. In the current study, the induction of hepatic CYP 3A1 and 2B1 by DDE was correlated with CAR and PXR activity. Induction of 3A1 and 2B1 was observed in the livers of adult and developing male Sprague-Dawley rats following exposure to DDE. Increased hepatic expression of 3A1, but not 2B1, in developing rats exposed during gestation and lactation persisted into adulthood. In receptor transactivation assays, both CAR and PXR transcriptional activities were significantly enhanced by DDE. Nuclear accumulation of CAR, but not PXR, was observed in the liver tissue following DDE and PB treatment. These data support the idea that induction of hepatic 3A1 and 2B1 by DDE is mediated through the activation of CAR and PXR. This study suggests that regulation by environmental compounds of hepatic enzymes via CAR and PXR may have impact on the metabolism of endogenous and exogenous substrates.


Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Diclorodifenil Dicloroetileno/análogos & derivados , Diclorodifenil Dicloroetileno/farmacologia , Poluentes Ambientais/farmacologia , Hepatócitos/efeitos dos fármacos , Receptores Citoplasmáticos e Nucleares/metabolismo , Receptores de Esteroides/metabolismo , Fatores de Transcrição/metabolismo , Animais , Hidrocarboneto de Aril Hidroxilases/metabolismo , Receptor Constitutivo de Androstano , Citocromo P-450 CYP2B1/metabolismo , Citocromo P-450 CYP3A , Feminino , Hepatócitos/enzimologia , Masculino , Oxirredutases N-Desmetilantes/metabolismo , Receptor de Pregnano X , Ratos , Ratos Sprague-Dawley
15.
Toxicol Sci ; 68(2): 295-303, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12151625

RESUMO

The determination of differences in hormonal regulation of tumor promotion-related response to 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD) between males and females may identify factors contributing to the female-specific hepatocarcinogenicity of TCDD in rats. In the current study, diethylnitrosamine-initiated male Sprague-Dawley rats were exposed to TCDD or corn oil vehicle in the presence and absence of 17beta-estradiol (E2), and cell proliferation and development of preneoplastic altered hepatic foci (AHF) were determined. After 30 weeks of exposure, gamma-glutamyltranspeptidase (GGT)-positive AHF and the number of placental glutathione-s-transferase (PGST)-positive AHF were significantly higher in TCDD-treated rats than in control rats. Both the number and volume fraction of GGT-positive AHF were significantly lower in rats cotreated with E2 regardless of TCDD exposure compared with corresponding non-E2-treated groups and were unaffected by TCDD. In contrast, the number of PGST-positive AHF was significantly higher in E2-treated rats in the absence of TCDD treatment. In addition, whereas E2 had no effect on the volume fraction of PGST-positive foci, the levels in rats cotreated with both E2 and TCDD were significantly higher than in controls. No differences were observed in cell proliferation between TCDD-treated and control rats, although cell proliferation was lower in rats exposed to E2 compared with placebo controls. The weaker potency of tumor promotion and lack of induction of cell replication and DNA damage in male rats likely explain the female-specific hepatocarcinogenicity of TCDD in chronic bioassays.


Assuntos
Carcinógenos/toxicidade , Estradiol/toxicidade , Neoplasias Hepáticas Experimentais/patologia , Dibenzodioxinas Policloradas/toxicidade , Lesões Pré-Cancerosas/patologia , Animais , Testes de Carcinogenicidade , Carcinógenos/administração & dosagem , Divisão Celular/efeitos dos fármacos , Citocromo P-450 CYP1A1/biossíntese , Citocromo P-450 CYP1A1/genética , Dietilnitrosamina/toxicidade , Antagonismo de Drogas , Estradiol/administração & dosagem , Glutationa Transferase/metabolismo , Neoplasias Hepáticas Experimentais/induzido quimicamente , Neoplasias Hepáticas Experimentais/enzimologia , Masculino , Dibenzodioxinas Policloradas/administração & dosagem , Lesões Pré-Cancerosas/induzido quimicamente , Lesões Pré-Cancerosas/enzimologia , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Reação em Cadeia da Polimerase Via Transcriptase Reversa , gama-Glutamiltransferase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA